[HTML][HTML] Prevalence and predictors of nonadherence to direct oral anticoagulant treatment in patients with atrial fibrillation
SFB van der Horst, TAC de Vries, G Chu, R Bavalia… - TH Open, 2023 - thieme-connect.com
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
S van der Horst, T de Vries, G Chu… - TH Open: Companion …, 2023 - europepmc.org
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
[HTML][HTML] Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
SFB van der Horst, TAC de Vries, G Chu… - TH Open: Companion …, 2023 - ncbi.nlm.nih.gov
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
SFB van der Horst… - TH open …, 2023 - researchinformation.amsterdamumc …
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
SFB van der Horst, TAC de Vries, G Chu, R Bavalia… - TH Open, 2023 - thieme-connect.com
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
[PDF][PDF] Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation.
SFB van der Horst, TAC de Vries, G Chu, R Bavalia… - 2023 - repository.ubn.ru.nl
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation
SFB van der Horst, TAC de Vries… - … to thrombosis and …, 2023 - pubmed.ncbi.nlm.nih.gov
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
Prevalence and Predictors of Nonadherence to Direct Oral Anticoagulant Treatment in Patients with Atrial Fibrillation.
SFB van der Horst, TAC de Vries, G Chu… - TH Open: Companion …, 2023 - europepmc.org
Background For most patients with newly diagnosed atrial fibrillation (AF), direct oral
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …
anticoagulants (DOACs) are preferred over vitamin K antagonists. However, there is concern …